A projection has been made that Roche will become the top global-grossing pharmaceutical company 5 years from now in 2028. Evaluate, the global pharmaceutical market analysis institution that released such projections, also predicted that Keytruda would take over Humira’s throne and become the No. 1 grossing drug among pharmaceuticals.

On the 24th, KoreaBIO cited Evaluate’s data and predicted the top-grossing pharmaceutical companies and drugs for 2023.

According to KoreaBIo’s projections, biopharmaceutical companies that have been producing results will be in the top ranks this year. The top-grossing company 5 years from now will be Roche, supported by the sales of its immuno-oncology dr